Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lensar Inc (NQ: LNSR )

7.450 UNCHANGED
Streaming Delayed Price Updated: 1:53 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lensar Inc

< Previous 1 2 3 Next >
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
LENSAR Reports First Quarter 2023 Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
Earnings Preview For LENSAR
Via Benzinga
LENSAR to Report First Quarter 2023 Financial Results on Monday, May 15, 2023
From LENSAR, Inc.
Via Business Wire
LENSAR Earnings Perspective: Return On Capital Employed
Via Benzinga
A Preview Of LENSAR's Earnings
Via Benzinga
LENSAR Earnings Perspective: Return On Capital Employed
Via Benzinga
LENSAR: Q2 Earnings Insights
  LENSAR (NASDAQ:LNSR) reported its Q2 earnings results on Monday, August 8, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023
From LENSAR, Inc.
Via Business Wire
LENSAR Announces Preliminary Fourth Quarter and Full Year 2022 Results
From LENSAR, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 49 companies hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  OnFriday, 143 stocks hit new 52-week lows. 
Via Benzinga
Why Lensar Shares Are Trading Higher Today
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  During Wednesday's session, 107 stocks hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 79 companies reached new 52-week lows. 
Via Benzinga
LENSAR to Present at Two Upcoming Investor Conferences
From LENSAR, Inc.
Via Business Wire
Why Drive Shack Shares Jumped Over 23%; Here Are 76 Biggest Movers From Yesterday
Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash. 
Via Benzinga
LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
LENSAR to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022
From LENSAR, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 85 stocks hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  During Friday's session, 41 companies made new 52-week lows. 
Via Benzinga
LENSAR Announces Application for Certification of the ALLY™ Adaptive Cataract Treatment System in the EU
From LENSAR, Inc.
Via Business Wire
LENSAR Earnings Perspective: Return On Capital Employed
LENSAR (NASDAQ:LNSR) brought in sales totaling $8.04 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 1.27%, resulting in a loss of $6.76 million. 
Via Benzinga
First Patients Treated with LENSAR’s® ALLY™ Adaptive Cataract Treatment System
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Second Quarter 2022 Financial Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
Earnings Outlook For LENSAR
LENSAR (NASDAQ:LNSR) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement. Analysts estimate that LENSAR will report an... 
Via Benzinga
LENSAR to Report Second Quarter 2022 Financial Results on Monday, August 8, 2022
From LENSAR, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.